Infectious keratopathy complicating photorefractive keratectomy.
Hill
V E
VE
Brownstein
S
S
Jackson
W B
WB
Mintsioulis
G
G
D000328:Adult; D002437:Cefazolin / Q000627:therapeutic use; D002939:Ciprofloxacin / Q000627:therapeutic use; D003315:Cornea / Q000382:microbiology* / Q000473:pathology; D003320:Corneal Ulcer / Q000209:etiology* / Q000473:pathology / Q000628:therapy; D004359:Drug Therapy, Combination; D015818:Eye Infections, Bacterial / Q000209:etiology* / Q000473:pathology / Q000628:therapy; D006801:Humans; D015948:Keratoplasty, Penetrating; D054018:Lasers, Excimer; D008297:Male; D009216:Myopia / Q000601:surgery; D009883:Ophthalmic Solutions; D018903:Photorefractive Keratectomy / Q000009:adverse effects*; D013203:Staphylococcal Infections / Q000209:etiology* / Q000473:pathology / Q000628:therapy; D013211:Staphylococcus aureus / Q000302:isolation & purification; D014326:Tropanes / Q000627:therapeutic use
D009883:Ophthalmic Solutions; D014326:Tropanes; D002939:Ciprofloxacin; C100236:homatropine; D002437:Cefazolin